About Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
Market Cap
$0.15B
Employees
61
Listed Since
May 3, 1994
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.nektar.comPhone
(415) 482-5300
Headquarters
455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO, CA 94158
CIK
0000906709